Skip to Content


Active Substance: depreotide trifluoroacetate
Common Name: depreotide
ATC Code: V09IA05
Marketing Authorisation Holder: CIS bio international
Active Substance: depreotide trifluoroacetate
Status: Withdrawn
Authorisation Date: 2000-11-29
Therapeutic Area: Radionuclide Imaging
Pharmacotherapeutic Group: Diagnostic radiopharmaceuticals

Therapeutic Indication

This medicinal product is for diagnostic use only.
For scintigraphic imaging of suspected malignant tumours in the lung after initial detection, in
combination with CT scan or chest X-ray, in patients with solitary pulmonary nodules.

The marketing authorisation for NeoSpect has been withdrawn at the request of the marketing authorisation holder.

Source: European Medicines Agency

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.